MedPath

Improved Bowel Cleansing Method for Colonoscopy Based on High Risk Population of Bowel Preparation

Not Applicable
Conditions
Bowel Preparation Before Colonoscopy
Interventions
Drug: PEG+lactulose
Drug: CSP+lactulose
Registration Number
NCT05498714
Lead Sponsor
Renmin Hospital of Wuhan University
Brief Summary

The purpose of this study is to observe the difference in bowel preparation quality between compound sodium picosulfate#CSP combined with lactulose and polyethylene glycol electrolyte#PEG combined with lactulose in high-risk population.

Detailed Description

The quality of bowel preparation is crucial for colonoscopy. Some high-risk factors for inadequate bowel preparation have been identified , including age \>70, previous colon surgery, constipation, diabetes, Parkinson's disease, history of stroke or spinal cord injury, prior history of inadequate bowel preparation, body mass index (BMI) \>25, use of tricyclic antidepressant or narcotics. Patients were considered as high risk if they have any of the above factors.This is a single-center ,endoscopist-blinded study to compare the efficacy of CSP combined with lactulose and PEG combined with lactulose in bowel preparation. In colonoscopy procedures, endoscopists who were blinded to the intervention evaluated the overall quality of colonoscopy cleaning according to the Boston Bowel Preparation Scale. Patients' tolerance, defecation, adverse events and adenoma detection rate (ADR) were also evaluated.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria

Adults undergoing colonoscopy who have at least one risk factor: age>70, previous colon surgery, constipation, diabetes, Parkinson's disease, history of stroke or spinal cord injury, prior history of inadequate bowel preparation, body mass index (BMI) >25, use of tricyclic antidepressant or narcotics.

Read More
Exclusion Criteria
  1. presence of any contraindications for colonoscopy (gastrointestinal obstruction or perforation,severe acute inflammatory bowel disease,toxic megacolon,severe heart failure,unable to swallow,severe heart failure,etc);
  2. Patients with galactosemia;
  3. hypersensitivity to any of the ingredients;
  4. Pregnancy or lactation;
  5. Use of lactulose,prokinetic agents or purgatives within 7 days;
  6. Unwilling to sign informed consent.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
the control groupPEG+lactuloseThe dosing regimen of high-risk patients will be PEG combined with lactulose.
CSP+lactulose groupCSP+lactuloseThe dosing regimen of high-risk patients will be CSP combined with lactulose.
Primary Outcome Measures
NameTimeMethod
Boston Bowel Preparation Scaleduring colonoscopy

Cleanliness of the colon during colonoscopy will be evaluated by the Boston Bowel Preparation Scale which is a 4-point scoring system applied to each of 3 broad regions of the colon: the right side, the transverse section, and the left side. The total BBPS score ranged from 0 to 9. If total BostonBowel Preparation Score ≥6 with each segmental BBPS≥2, we regard it as adequate bowel preparation.

Secondary Outcome Measures
NameTimeMethod
Adenoma Detection Rate2 days

Diagnosis was confirmed by histologic examination

Rate of adverse events2 days

adverse events, such as vomiting, nausea, headache, abdominal distention, abdominal pain.

Cecal intubation rateduring colonoscopy

Colonoscopy reaches cecal region.

Polyp Detection Rate2 days

Diagnosis was confirmed by histologic examination

defecation frequency2 days

Frequency of bowel movement.

Cecal intubation timeduring colonoscopy

Colonoscopy reaches cecal region.

Withdrawal timeduring colonoscopy

The time from the cecum to the anus, but excluded time for biopsy performance or removal of polyps.

patient satisfaction Assessment2 days

Patients' satisfaction score for bowel preparation (3 points: completely tolerable and very satisfied; 2 points: nausea and other discomfort, but still tolerable and satisfactory; 1: unable to tolerate, not satisfied);

And whether the patient is willing to use the bowel cleansing program for colonoscopy;

Trial Locations

Locations (1)

Renmin Hospital of Wuhan University

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath